Downstate alumnus Ralph Snyderman, MD ’65, Duke University Chancellor Emeritus and the James B. Duke Professor of Medicine, will present “From Brooklyn to Duke’s Chancellor for Health Affairs: Lessons Learned” March 21 as the AOA annual lecture.
The reception and lecture are open to the public, but the AOA awards dinner to follow is by invitation only.
ATA Chapter of the Alpha Omega Alpha Honor Society Annual AOA Reception, Lecture and Awards Dinner Tuesday, March 21, 2017 Deity Events, 368 Atlantic Avenue, Brooklyn, 11217
For more information, visit the AOA site, here, or call the Alumni Association-College of Medicine for SUNY Downstate at 718-270-2075.
If you can’t make it in person, make sure we have your correct email address. We’ll include a link to a transcript or filmed version of the lecture in our email newsletter within the next few months.
Ralph Snyderman, MD ’65 From Duke University
Dr. Ralph Snyderman served as Chancellor for Health Affairs at Duke University and Dean of the School of Medicine from 1989 to July 2004 and led the transition of this excellent medical center into an internationally recognized leader of academic medicine. During his tenure, the medical school and hospital achieved ranking amongst the nation’s best. He oversaw the development of the Duke University Health System, one of the most successful integrated academic health systems in the country, and served as its first President and Chief Executive Officer. Dr. Snyderman has played a leading role in the conception and development of Personalized Health Care, an evolving model of national health care delivery. He was among the first to envision and articulate the need to move the current focus of health care from the treatment of disease-events to personalized, predictive, preventative, and participatory care that is focused on the patient. In 2012, Dr. Snyderman received the David E. Rogers Award from the Association of American Medical Colleges who referred to him as the “father of personalized medicine.”
Dr. Snyderman has been widely recognized for his contributions to the development of personalized health care, a more rational, effective, and compassionate model of health care. He was awarded the first Bravewell Leadership Award for outstanding achievements in the field of integrative medicine in 2003. In 2007, he received the Leadership in Personalized Medicine Award from the Personalized Medicine Coalition for his efforts in advancing predictive and targeted therapies on a national scale. In 2008, Dr. Snyderman received Frost & Sullivan’s North American HealthCare Lifetime Achievement Award for his pioneering spirit and contributions to medicine. In 2009, he received the Triangle Business Journal’s Healthcare Lifetime Achievement Award. In 2010, Procter & Gamble named Snyderman an honorary member of the Victor Mills Society for his leadership and impact on innovation and he was recognized as a Bioscience Leader Emeriti by the NC Association for Biomedical Research honoring North Carolina research leaders for their outstanding leadership in the transformation of the state through scientific discovery and innovation. In 2012, Dr. Snyderman received the David E. Rogers Award from the Association of American Medical Colleges for his leadership in academic medicine and for the conception of personalized medicine. Dr. Snyderman was awarded the North Carolina Life Sciences Leadership Award in February 2014.
Dr. Snyderman has played a prominent role in the leadership of such important national organizations as the Association of American Physicians, the Institute of Medicine and the Association of American Medical Colleges. He is a member of the Institute of Medicine and the American Academy of Arts & Sciences. He served as Chair of the AAMC in 2001-2002 and President of AAP in 2003-2004. He chaired the Institute of Medicine’s National Summit on Integrative Medicine and the Health of the Public held in February 2009.
Dr. Snyderman accepted his first faculty appointment at Duke in 1972 and by 1984, he was the Frederic M. Hanes Professor of Medicine and Immunology. His research contributed to the understanding of how white blood cells respond to chemical signals to mediate host defense or tissue damage and he is internationally recognized for his contributions in inflammation research. In 1987, Snyderman left Duke to join Genentech, Inc., the pioneering biomedical technology firm, as Senior Vice President for medical research and development. While at Genentech, he led the development and licensing of several major biotechnology therapeutics.
Support Downstate medical students today! Join the Association Update your information to receive the monthly newsletter Give to scholarship funds that prepare tomorrow’s heath pioneers